Cash Flow

v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (8,529,843) $ (9,752,197)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 4,722,137 8,582,203
Net loss on disposition or impairment (non-cash portion) 10,454,609 2,632,604
Net franchise fees recognized upon termination of franchise agreements (239,335) (217,827)
Deferred income taxes (55,556) 10,896,504
Provision for credit losses on accounts receivable 220,893 0
Stock based compensation expense 1,679,005 1,737,682
Changes in operating assets and liabilities:    
Accounts receivable (1,645,078) 192,348
Prepaid expenses and other current assets 160,082 (341,478)
Deferred franchise costs 499,285 355,952
Deposits and other assets 8,827 1,492
Accounts payable 68,258 (1,381,836)
Accrued expenses 4,609,759 793,679
Payroll liabilities 2,398,765 1,455,234
Operating lease liabilities (3,796,648) (107,735)
Upfront regional developer fees (421,213) (598,778)
Deferred revenue (597,489) 301,095
Other liabilities (121,408) 128,647
Net cash provided by operating activities 9,415,050 14,677,589
Cash flows from investing activities:    
Acquisition of CA clinics 0 (1,188,765)
Proceeds from sale of clinics 554,100 0
Purchase of property and equipment (1,185,647) (4,999,070)
Net cash used in investing activities (631,547) (6,187,835)
Cash flows from financing activities:    
Payments of finance lease obligation (25,484) (24,432)
Purchases of treasury stock under employee stock plans (9,583) (3,833)
Proceeds from exercise of stock options 33,708 202,386
Repayment of debt under the Credit Agreement (2,000,000) 0
Net cash (used in) provided by financing activities (2,001,359) 174,121
Increase in cash 6,782,144 8,663,875
Cash, cash equivalents and restricted cash, beginning of period 19,214,292 10,550,417
Cash, cash equivalents and restricted cash, end of period 25,996,436 19,214,292
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 25,051,355 18,153,609
Restricted cash 945,081 1,060,683
Cash and cash equivalents and restricted cash 25,996,436 19,214,292
Net cash paid for:    
Interest 69,445 173,062
Income taxes 610,492 569,765
Unpaid purchases of property and equipment 124,699 140,055
Stock option exercise receivable 896,766 0
Non-cash investment in acquisition of franchised clinics 14,997,105 16,113,879
Franchise Fees Collected Upon Franchise Agreement    
Non-cash investment in acquisition of franchised clinics $ 0 $ 28,997

Source